Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study

BACKGROUND: Effects of dopaminergic medications used to treat Parkinson's disease (PD) may be compared with each other by using conversion factors, calculated as Levodopa equivalent dose (LED). However, current LED proposals on MAO‐B inhibitors (iMAO‐B) safinamide and rasagiline are still based...

Descripción completa

Detalles Bibliográficos
Autores principales: Cilia, Roberto, Cereda, Emanuele, Piatti, Marco, Pilotto, Andrea, Magistrelli, Luca, Golfrè Andreasi, Nico, Bonvegna, Salvatore, Contaldi, Elena, Mancini, Francesca, Imbalzano, Gabriele, De Micco, Rosa, Colucci, Fabiana, Braccia, Arianna, Bellini, Gabriele, Brovelli, Francesco, Zangaglia, Roberta, Lazzeri, Giulia, Russillo, Maria Claudia, Olivola, Enrica, Sorbera, Chiara, Cereda, Viviana, Pinto, Patrizia, Sucapane, Patrizia, Gelosa, Giorgio, Meloni, Mario, Pistoia, Francesca, Sessa, Maria, Canesi, Margherita, Modugno, Nicola, Pacchetti, Claudio, Brighina, Laura, Pellecchia, Maria Teresa, Ceravolo, Roberto, Sensi, Mariachiara, Zibetti, Maurizio, Comi, Cristoforo, Padovani, Alessandro, Zecchinelli, Anna L., Di Fonzo, Alessio, Tessitore, Alessandro, Morgante, Francesca, Eleopra, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105110/
https://www.ncbi.nlm.nih.gov/pubmed/37070060
http://dx.doi.org/10.1002/mdc3.13681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105110/
https://www.ncbi.nlm.nih.gov/pubmed/37070060
http://dx.doi.org/10.1002/mdc3.13681

Ejemplares similares